Baoshan Cao

5PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 04, 2026
Chemically Masked aPD-L1-Sialidase Conjugate for Tumor-Specific Desialylation and Immunotherapy.

|Aug 27, 2025
Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review.

Jinyu Yu, Xuanjun Liu, Xingjiao Ma

|Jan 11, 2024
A study protocol for an open-label, single-arm, single-center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.

Huiying Huang, Hua Zhang, Baoshan Cao

|Nov 29, 2021
Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey.

Yan'e Liu, Yanhong Yao, Qiqi Wang

|May 08, 2020
Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol.

Yan'e Liu, Jie Zhang, Zhongnan Yin

Pageof 1

Frequent Collaborators

1 joint publications

Yan'e Liu

1 joint publications

Jie Zhang

1 joint publications

Lixiang Xue

1 joint publications

Yangchun Gu